These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10188730)

  • 41. Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy.
    Terzic T; Cordeau M; Herblot S; Teira P; Cournoyer S; Beaunoyer M; Peuchmaur M; Duval M; Sartelet H
    Pediatr Dev Pathol; 2018; 21(4):355-362. PubMed ID: 29067879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.
    Eger C; Siebert N; Seidel D; Zumpe M; Jüttner M; Brandt S; Müller HP; Lode HN
    PLoS One; 2016; 11(3):e0150479. PubMed ID: 26967324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
    Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
    Oncol Rep; 2003; 10(5):1587-92. PubMed ID: 12883745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.
    Goren D; Horowitz AT; Zalipsky S; Woodle MC; Yarden Y; Gabizon A
    Br J Cancer; 1996 Dec; 74(11):1749-56. PubMed ID: 8956788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BBC3 mediates fenretinide-induced cell death in neuroblastoma.
    Wei JS; Whiteford CC; Cenacchi N; Son CG; Khan J
    Oncogene; 2005 Dec; 24(54):7976-83. PubMed ID: 16091745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
    Shan D; Gopal AK; Press OW
    Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
    Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
    Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
    Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma.
    Saleh MN; Khazaeli MB; Wheeler RH; Allen L; Tilden AB; Grizzle W; Reisfeld RA; Yu AL; Gillies SD; LoBuglio AF
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):19-24. PubMed ID: 1576319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration.
    Carosio R; Pistoia V; Orienti I; Formelli F; Cavadini E; Mangraviti S; Montaldo PG; Ognio E; Emionite L; Zuccari G
    J Pharm Pharmacol; 2012 Feb; 64(2):228-36. PubMed ID: 22221098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
    Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.
    Heiss P; Bermatz S; Wehnes H; Heinzmann U; Senekowitsch-Schmidtke R
    Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy.
    Jose G; Lu YJ; Hung JT; Yu AL; Chen JP
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33142721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells.
    Allen TM; Brandeis E; Hansen CB; Kao GY; Zalipsky S
    Biochim Biophys Acta; 1995 Jul; 1237(2):99-108. PubMed ID: 7632714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Pyrazolo[3,4-
    Rango E; Pastorino F; Brignole C; Mancini A; Poggialini F; Di Maria S; Zamperini C; Iovenitti G; Fallacara AL; Sabetta S; Clementi L; Valoti M; Schenone S; Angelucci A; Ponzoni M; Dreassi E; Botta M
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects on M5076-hepatic metastasis of retinoic acid and N-(4-hydroxyphenyl) retinamide, fenretinide entrapped in SG-liposomes.
    Takahashi N; Tamagawa K; Shimizu K; Fukui T; Maitani Y
    Biol Pharm Bull; 2003 Jul; 26(7):1060-3. PubMed ID: 12843642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.
    Siebert N; Seidel D; Eger C; Brackrock D; Reker D; Schmidt M; Lode HN
    J Immunol Methods; 2013 Dec; 398-399():51-9. PubMed ID: 24055592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.
    Mueller BM; Reisfeld RA; Gillies SD
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5702-5. PubMed ID: 2198570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.